Operating Lease, Right-of-Use Asset of Centessa Pharmaceuticals plc from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Centessa Pharmaceuticals plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Centessa Pharmaceuticals plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $10,295,000, a 8.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Centessa Pharmaceuticals plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,295,000 -$949,000 -8.4% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $10,539,000 -$932,000 -8.1% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $10,778,000 -$916,000 -7.8% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $11,013,000 -$901,000 -7.6% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $11,244,000 -$886,000 -7.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $11,471,000 -$871,000 -7.1% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $11,694,000 -$577,000 -4.7% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $11,914,000 +$11,914,000 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $12,130,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $12,342,000 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $12,271,000 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $0 31 Dec 2022 10-K 28 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.